Cover Image
市場調查報告書

整形外科設備的中國市場中研究開發預測:2015∼2020年

Research and Development Forecast of Orthopedic Device Market in China, 2015-2020

出版商 Huidian Research 商品編碼 329460
出版日期 內容資訊 英文 73 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
整形外科設備的中國市場中研究開發預測:2015∼2020年 Research and Development Forecast of Orthopedic Device Market in China, 2015-2020
出版日期: 2015年04月30日 內容資訊: 英文 73 Pages
簡介

近幾年,蛋白分解酵素,人造器官,植入設備產業的市場規模擴大著為持續的,收益急速也持續伸長。根據統計,以2014年終市場規模是92億3,000元,從2013年開始成為21.93%提高。

本報告提供中國的整形外科設備市場相關調查,市場概要與環境分析,市場發展預測,進出口趨勢,以及主要企業的簡介等彙整。

第1章 整形外科設備產業概要

  • 定義
  • 分類
  • 發展歷史

第2章 中國的整形外科設備產業環境分析

  • 經濟環境
    • 開發趨勢
    • 中國的GDP
    • 固定資產投資
  • 社會環境
  • 政治環境

第3章 中國的整形外科設備產業的市場發展

  • 發展現況
    • 市場規模
    • 市場區隔
    • 市場特性
    • 中國的植入人體的醫療材料的分類
    • 技術的萬能性
  • 經濟情況
    • 蛋白分解酵素、人造器官、植入設備產業的市場規模
    • 蛋白分解酵素、人造器官、植入醫療設備的利益
    • 蛋白分解酵素、人造器官、植入醫療設備的損失
    • 蛋白分解酵素、人造器官、植入醫療設備的盈利
    • 蛋白分解酵素、人造器官、植入醫療設備的負債返還能力
  • 市場競爭格局與趨勢
  • 經營模式
  • 上游,下游的開發

第4章 中國的整形外科設備的進出口

  • 整形外科或骨折所採用設備的進出口
  • 人工關節產品的進出口

第5章 中國的主要整形外科設備企業

  • Johnson & Johnson (China) Investment Ltd.
  • Medtronic, Inc.
  • Stryker Corporation
  • Trauson Holdings
  • China Kanghui Holdings
  • Shandong Weigao Group Medical Polymer Company Limited
  • Xian Airfoil Technology Co., Ltd.
  • LINK Orthopedics (China) Co., Ltd.
  • Changzhou BIOMET Medical Device Co., Ltd.
  • Beijing Montagne Medical Device Co., Ltd.
  • Tianjin Walkman Biomaterial Co., Ltd.
  • Suzhou Xinrong Best Medical Instrument Co., Ltd.

第6章 整形外科設備產業的發展預測和競爭改善的建議

  • 發展預測
  • 對改善產業競爭的對策提案
    • 國家政策支援和保護
    • 企業自身優勢的強化
目錄

Market Development of Orthopedic Device Industry in China

Economic Operation

Market Scale of Prostheses, Artificial Organs and Implantable (Interventional) Device Industry, 2010-2014

In recent years, the market scale of prostheses, artificial organs and implantable (interventional) device industry is enlarging constantly and industry revenue keeps growing rapidly. Statistics suggest: by the end of 2014, the market scale was CNY 9.23 billion in China, up 21.93% over 2013, as shown in the following fig.:

Profit of Prostheses, Artificial Organs and Implantable (Interventional) Medical Devices Industry, 2010-2014

Statistics suggested: in 2010, the profit of prostheses, artificial organs and implantable (interventional) medical devices industry was CNY 720 million; by the end of 2014, the industry profit was CNY 1.81 billion, the profit level was improved continually, as shown in the following fig.:

Loss of Prostheses, Artificial Organs and Implantable (Interventional) Medical Device Industry, 2010-2014

In recent years, with the development of prostheses, artificial organs and implantable (interventional) medical device industry in China, the number of loss-making enterprises is reducing constantly, as shown in the following fig.:

Profitability Level of Prostheses, Artificial Organs and Implantable (Interventional) Medical Devices Industry, 2010-2014

In recent years, the profitability level of prostheses, artificial organs and implantable (interventional) medical devices industry in China is improved continually. By the end of 2014, the industry gross profit rate was 50.36%. As shown in the following fig.:

Debt-Paying Ability of Prostheses, Artificial Organs and Implantable (Interventional) Medical Device Industry, 2010-2014

The debt-paying ability of prostheses, artificial organs and implantable (interventional) medical devices industry in China is improved constantly. Statistics suggested: by the end of 2014, the industry's debt to assets ratio was 44.25%.

Table of Contents

1. Overview of Orthopedic Device Industry

  • 1.1. Definition
  • 1.2. Classification
  • 1.3. Development History

2. Environment Analysis of Orthopedic Device Industry in China

  • 2.1. Economic Environment
    • 2.1.1. Development Status
    • 2.1.2. GDP in China
    • 2.1.3. Fixed Asset Investment
  • 2.2. Social Environment
  • 2.3. Policy Environment
    • 2.3.1. Industry Supervision Status
    • 2.3.2. Industry Supervision System
    • 2.3.3. National Industry Policies

3. Market Development of Orthopedic Device Industry in China

  • 3.1. Development Status Quo
    • 3.1.1. Market Scale
    • 3.1.2. Market Segments
    • 3.1.3. Market Characteristics
    • 3.1.4. Categories of Medical Materials Implanted Into Human Body in China
    • 3.1.5. Technical Versatility
  • 3.2. Economic Operation
    • 3.2.1. Market Scale of Prostheses, Artificial Organs and Implantable (Interventional) Device Industry, 2010-2014
    • 3.3.2. Profit of Prostheses, Artificial Organs and Implantable (Interventional) Medical Devices Industry, 2010-2014
    • 3.2.3. Loss of Prostheses, Artificial Organs and Implantable (Interventional) Medical Devices Industry, 2010-2014
    • 3.2.4. Profitability Level of Prostheses, Artificial Organs and Implantable (Interventional) Medical Devices Industry, 2010-2014
    • 3.2.5. Debt-Paying Ability of Prostheses, Artificial Organs and Implantable (Interventional) Medical Devices, 2010-2014
  • 3.3. Market Competition Pattern and Trend
  • 3.4. Business Model
  • 3.5. Upstream and Downstream Development
  • 3.6. Periodicity, Regionality and Seasonality
    • 3.6.1. Periodicity
    • 3.6.2. Regionality
    • 3.6.3. Seasonality

4. Imports and Exports of Orthopedic Devices in China

  • 4.1. Imports & Exports of Devices Used for Orthopedics or Bone Fracture
  • 4.2. Imports & Exports of Artificial Joint Products

5. Key Orthopedic Device Enterprises in China

  • 5.1. Johnson & Johnson (China) Investment Ltd.
    • 5.1.1. Company Profile
    • 5.1.2. Business Performance
    • 5.1.3. Future Development
  • 5.2. Medtronic, Inc.
    • 5.2.1. Company Profile
    • 5.2.2. Business Performance
    • 5.2.3. Mergers and Acquisitions
    • 5.2.4. Future Development
  • 5.3. Stryker Corporation
    • 5.3.1. Company Profile
    • 5.3.2. Business Performance
    • 5.3.3. Acquire Trauson Holdings
  • 5.4. Trauson Holdings
    • 5.4.1. Company Profile
    • 5.4.2. Business Performance
    • 5.4.3. Future Development
  • 5.5. China Kanghui Holdings
    • 5.5.1. Company Profile
    • 5.5.2. Business Performance
    • 5.5.3. Competitiveness
  • 5.6. Shandong Weigao Group Medical Polymer Company Limited
    • 5.6.1. Company Profile
    • 5.6.2. Business Performance
    • 5.6.3. Sales and Marketing Promotion
    • 5.6.4. Business Review and Prospect
  • 5.7. Xian Airfoil Technology Co., Ltd.
    • 5.7.1. Company Profile
    • 5.7.2. Main Products and Processing Technology
    • 5.7.3. Business Performance
    • 5.7.4. Management Ability
  • 5.8. LINK Orthopedics (China) Co., Ltd.
    • 5.8.1. Company Profile
    • 5.8.2. Production Equipment, Technology and Production Capacity
    • 5.8.3. Future Development
  • 5.9. Changzhou BIOMET Medical Device Co., Ltd.
    • 5.9.1. Company Profile
    • 5.9.2. Main Products
    • 5.9.3. Business Performance
  • 5.10. Beijing Montagne Medical Device Co., Ltd.
    • 5.10.1. Company Profile
    • 5.10.2. Business Performance
    • 5.10.3. Competitiveness
  • 5.11. Tianjin Walkman Biomaterial Co., Ltd.
    • 5.11.1. Company Profile
    • 5.11.2. Business Performance
    • 5.11.3. Competitiveness

5.12. Suzhou Xinrong Best Medical Instrument Co., Ltd.

    • 5.12.1. Company Profile
    • 5.12.2. Business Performance
    • 5.12.3. Competitiveness
    • 5.12.4. Future Development

6. Development Forecast and Recommendations on Improving Competitiveness of Orthopedic Device Industry, 2015-2020

  • 6.1. Development Forecast
  • 6.2. Countermeasures and Suggestions on Improving Industrial Competitiveness
    • 6.2.1. National Policy Support and Protection
    • 6.2.2. Self-strength Improvement of Enterprises
Back to Top